Roundview Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $659K | Sell |
1,315
-2,398
| -65% | -$1.15M | 0.04% | 251 |
|
|
2026
Q1 | $1.83M | Buy |
3,713
+74
| +2% | +$40.2K | 0.11% | 160 |
|
|
2025
Q4 | $2.11M | Sell |
3,639
-79
| -2% | -$44.7K | 0.13% | 149 |
|
|
2025
Q3 | $1.8M | Sell |
3,718
-67
| -2% | -$31.2K | 0.11% | 159 |
|
|
2025
Q2 | $1.53M | Sell |
3,785
-3,304
| -47% | -$1.38M | 0.1% | 175 |
|
|
2025
Q1 | $3.53M | Buy |
7,089
+26
| +0.4% | +$14.1K | 0.25% | 92 |
|
|
2024
Q4 | $3.67M | Buy |
7,063
+15
| +0.2% | +$8.25K | 0.26% | 88 |
|
|
2024
Q3 | $4.36M | Buy |
7,048
+86
| +1% | +$50.9K | 0.32% | 76 |
|
|
2024
Q2 | $3.85M | Sell |
6,962
-50
| -0.7% | -$28.6K | 0.3% | 76 |
|
|
2024
Q1 | $4.08M | Buy |
7,012
+609
| +10% | +$342K | 0.33% | 69 |
|
|
2023
Q4 | $3.4M | Sell |
6,403
-99
| -2% | -$47.9K | 0.31% | 71 |
|
|
2023
Q3 | $3.29M | Sell |
6,502
-52
| -0.8% | -$27.7K | 0.33% | 78 |
|
|
2023
Q2 | $3.42M | Buy |
6,554
+772
| +13% | +$417K | 0.33% | 76 |
|
|
2023
Q1 | $3.33M | Buy |
5,782
+149
| +3% | +$84K | 0.35% | 76 |
|
|
2022
Q4 | $3.1M | Buy |
5,633
+219
| +4% | +$116K | 0.35% | 77 |
|
|
2022
Q3 | $2.75M | Buy |
5,414
+97
| +2% | +$54.3K | 0.35% | 79 |
|
|
2022
Q2 | $2.89M | Sell |
5,317
-362
| -6% | -$199K | 0.35% | 80 |
|
|
2022
Q1 | $3.35M | Buy |
5,679
+179
| +3% | +$103K | 0.34% | 81 |
|
|
2021
Q4 | $3.67M | Buy |
5,500
+472
| +9% | +$295K | 0.37% | 73 |
|
|
2021
Q3 | $2.87M | Buy |
5,028
+164
| +3% | +$90K | 0.32% | 84 |
|
|
2021
Q2 | $2.45M | Buy |
4,864
+1,034
| +27% | +$488K | 0.27% | 91 |
|
|
2021
Q1 | $1.75M | Buy |
3,830
+2
| +0.1% | +$955 | 0.22% | 120 |
|
|
2020
Q4 | $1.78M | Buy |
3,828
+85
| +2% | +$39.9K | 0.24% | 102 |
|
|
2020
Q3 | $1.65M | Buy |
3,743
+59
| +2% | +$24.4K | 0.26% | 97 |
|
|
2020
Q2 | $1.33M | Buy |
3,684
+44
| +1% | +$14.7K | 0.23% | 113 |
|
|
2020
Q1 | $1.03M | Buy |
3,640
+324
| +10% | +$102K | 0.22% | 117 |
|
|
2019
Q4 | $1.08M | Buy |
3,316
+11
| +0.3% | +$3.33K | 0.2% | 132 |
|
|
2019
Q3 | $963K | Hold |
3,305
| – | – | 0.21% | 133 |
|
|
2019
Q2 | $971K | Buy |
3,305
+25
| +0.8% | +$6.89K | 0.22% | 122 |
|
|
2019
Q1 | $898K | Buy |
+3,280
| New | +$816K | 0.21% | 123 |
|
|
2015
Q4 | – | Sell |
-18,123
| Closed | -$2.22M | – | 172 |
|
|
2015
Q3 | $2.22M | Hold |
18,123
| – | – | 0.95% | 26 |
|
|
2015
Q2 | $2.35M | Sell |
18,123
-2,600
| -13% | -$339K | 0.89% | 29 |
|
|
2015
Q1 | $2.78M | Buy |
+20,723
| New | +$2.67M | 1.1% | 21 |
|
Other funds holding TMO
Roundview Capital's TMO Position: Q2 2026 in Review
Roundview Capital reduced its Thermo Fisher Scientific (TMO) stake by 65% in Q2 2026, selling an estimated $1.15M and leaving 1,315 shares worth $659K. The position accounts for 0.04% of the portfolio, ranked #251.
Roundview Capital first reported a position in TMO in Q1 2015 and has held it in 33 quarters since. The position peaked at $4.36M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Roundview Capital held 1,315 shares of Thermo Fisher Scientific worth $659K as of Q2 2026.
- Roundview Capital sold 2,398 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.15M.
- Thermo Fisher Scientific made up 0.04% of Roundview Capital's portfolio in Q2 2026, its #251 holding.
- Roundview Capital first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 33 quarters since.
- Roundview Capital's Thermo Fisher Scientific position peaked at $4.36M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Roundview Capital's 13F filing for Q2 2026, filed 30 Jul 2026.